skip to main content
Idioma:
Refinado por: assunto: Female remover assunto: Multiple Myeloma - Drug Therapy remover Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Cavo, Michele ; Pantani, Lucia ; Petrucci, Maria Teresa ; Patriarca, Francesca ; Zamagni, Elena ; Donnarumma, Daniela ; Crippa, Claudia ; Boccadoro, Mario ; Perrone, Giulia ; Falcone, Antonietta ; Nozzoli, Chiara ; Zambello, Renato ; Masini, Luciano ; Furlan, Anna ; Brioli, Annamaria ; Derudas, Daniele ; Ballanti, Stelvio ; Dessanti, Maria Laura ; De Stefano, Valerio ; Carella, Angelo Michele ; Marcatti, Magda ; Nozza, Andrea ; Ferrara, Felicetto ; Callea, Vincenzo ; Califano, Catello ; Pezzi, Annalisa ; Baraldi, Anna ; Grasso, Mariella ; Musto, Pellegrino ; Palumbo, Antonio

Blood, 2012-07, Vol.120 (1), p.9-19 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma

Tosi, P ; Zamagni, E ; Cellini, C ; Ronconi, S ; Patriarca, F ; Ballerini, F ; Musto, P ; Di Raimondo, F ; Ledda, A ; Lauria, F ; Masini, L ; Gobbi, M ; Vacca, A ; Ria, R ; Cangini, D ; Tura, S ; Baccarani, M ; Cavo, M

Haematologica (Roma), 2002-04, Vol.87 (4), p.408-414 [Periódico revisado por pares]

Pavia: Haematologica

Texto completo disponível

Citações Citado por
3
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure

TOSI, P ; ZAMAGNI, E ; RONCONI, S ; BENNI, M ; MOTTA, M. R ; RIZZI, S ; TURA, S ; CAVO, M

Leukemia, 2000-07, Vol.14 (7), p.1310-1313 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
4
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

CAVO, M ; BANDINI, G ; MOTTA, M ; RIZZI, S ; TURA, S ; BENNI, M ; GOZZETTI, A ; RONCONI, S ; ROSTI, G ; ZAMAGNI, E ; LEMOLI, R ; BONINI, A ; BELARDINELLI, A

Bone marrow transplantation (Basingstoke), 1998-07, Vol.22 (1), p.27-32 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.